Book a demo
Research & KnowledgeEvent: September 1, 2026

Mativa Diagnostics published a landmark study in Blood Advances quantifying 75 years of blood cancer breakthroughs.

Published

Signal category

Research & Knowledge

Quote

A landmark study published today in Blood Advances quantified 75 years of blood cancer breakthroughs

Dean Remy|Mativa Diagnostics team

Company

Mativa Diagnostics

Mativa Dx is developing first-in-class pregnancy test also diagnostic for preeclampsia & ectopic pregnancies.

Industry
Biotechnology Research
Location
Doylestown, US
Company size
2 employees

Mativa Diagnostics is pioneering new levels of prenatal care. Our testing kit's Design and AI-enabled User Interface is modern, simple to use, and extremely sensitive, designed with women in mind to give them control and the information they need to make the best possible decision for themselves. Women's Health and Prenatal Viability Awareness will enable Affordable Life and Cost Saving Benefits to Women and to Healthcare Systems & Insurers

Founded 2024

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.

Mativa Diagnostics published a landmark study in Blood Advances quantifying 75 years of blood cancer breakthroughs. | SeedOps